# MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
Canonical URL: https://biopharmsignal.com/news/MKT/maia-biotechnology-announces-pricing-of-30-million-underwritten-public-offering-of-common-stock
Ticker: MKT
Company: Maia Biotechnology
Source: Maia Biotechnology
Published: 2026-03-03 03:45 EST
Original Source URL: https://ir.maiabiotech.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-08 13:45 EST — [MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial](https://biopharmsignal.com/news/MKT/maia-biotechnology-reports-strong-initial-efficacy-data-in-third-line-non-small--1bd9a96f) — Source: Maia Biotechnology
- 2026-06-25 12:08 EST — [MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer](https://biopharmsignal.com/news/MKT/maia-biotechnology-completes-international-enrollment-in-part-c-of-phase-2-thio--0735c98e) — Source: Maia Biotechnology
- 2026-06-18 12:30 EST — [MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University](https://biopharmsignal.com/news/MKT/maia-biotechnology-opens-enrollment-for-phase-2-expansion-trial-of-novel-telomer-d8f512f9) — Source: Maia Biotechnology
- 2026-06-10 13:15 EST — [MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial](https://biopharmsignal.com/news/MKT/maia-biotechnology-activates-and-opens-enrollment-at-second-u-s-clinical-site-fo-6dac7639) — Source: Maia Biotechnology
- 2026-06-04 13:45 EST — [MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial](https://biopharmsignal.com/news/MKT/maia-biotechnology-reports-strong-enrollment-and-dosing-momentum-in-pivotal-phas-00bc65f1) — Source: Maia Biotechnology
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)